Tara Bancroft
Stock Analyst at TD Cowen
(2.84)
# 1,737
Out of 4,876 analysts
8
Total ratings
66.67%
Success rate
27.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Initiates: Buy | $50 | $36.72 | +36.17% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $55.69 | +16.72% | 1 | Sep 24, 2024 | |
| OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $9.22 | +19.31% | 3 | Jun 20, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.49 | +571.14% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $52.95 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $7.24 | - | 1 | Aug 31, 2022 |
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $36.72
Upside: +36.17%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $55.69
Upside: +16.72%
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $9.22
Upside: +19.31%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.49
Upside: +571.14%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $52.95
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $7.24
Upside: -